DOM-ISONIAZID 300MG TABLETS 300 MG
ISONIAZID : 300 MG · DIN 02181428 · DOMINION PHARMACAL
Health Canada status: CANCELLED POST MARKET
What is DOM-ISONIAZID 300MG TABLETS?
DOM-ISONIAZID 300MG TABLETS 300 MG contains ISONIAZID : 300 MG. It is listed in the Health Canada Drug Product Database under DIN 02181428, held by DOMINION PHARMACAL, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Jul-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is DOM-ISONIAZID 300MG TABLETS used for?
null
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02181428 |
|---|---|
| Brand name | DOM-ISONIAZID 300MG TABLETS |
| Generic / active ingredient | ISONIAZID : 300 MG |
| Manufacturer | DOMINION PHARMACAL |
| Strength | 300 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J04AC01 ISONIAZID |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Jul-2025 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code J04AC01 ISONIAZID. 3 of 18 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PDP-ISONIAZID | 100 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 00577790 |
| PDP-ISONIAZID | 300 MG | Tablet | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 00577804 |
| PDP-ISONIAZID | 50 MG / 5 ML | SOLUTION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 00577812 |
| ISONIAZID SYRUP 50MG/5ML | 50 MG / 5 ML | SYRUP | CAROLINA MEDICAL PRODUCTS COMPANY | CANCELLED POST MARKET | DIN 00722464 |
| ISONIAZID TAB 100MG | 100 MG | TABLET | SANDS PHARM | CANCELLED POST MARKET | DIN 00440108 |
| ISONIAZID TAB 300MG | 300 MG | TABLET | SANDS PHARM | CANCELLED POST MARKET | DIN 00310247 |
| ISONIAZID TAB 50MG | 50 MG | TABLET | SANDS PHARM | CANCELLED POST MARKET | DIN 00382779 |
| ISONIAZIDE 100MG TABLETS | 100 MG | TABLET | LABORATOIRES CONFAB INC | CANCELLED PRE MARKET | DIN 02232756 |
| ISOTAMINE | 10 MG | SYRUP | BAUSCH HEALTH, CANADA INC. | DORMANT | DIN 00265500 |
| ISOTAMINE | 100 MG | TABLET | BAUSCH HEALTH, CANADA INC. | DORMANT | DIN 00261270 |
Who else supplies ISONIAZID worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ISONIAZID appears in 683 registered pack listings across 10 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.